Roles and Crosstalks of Macrophages in Diabetic Nephropathy

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2022 Nov 21

PMID 36405700

Authors

Hai-di Li

Yong-Ke You

Bao-Yi Shao

Wei-Feng Wu

Yi-Fan Wang

Jian-Bo Guo

Xiao-Ming Meng

Haiyong Chen

Affiliations

Soon will be listed here.

Abstract

Diabetic nephropathy (DN) is the most common chronic kidney disease. Accumulation of glucose and metabolites activates resident macrophages in kidneys. Resident macrophages play diverse roles on diabetic kidney injuries by releasing cytokines/chemokines, recruiting peripheral monocytes/macrophages, enhancing renal cell injuries (podocytes, mesangial cells, endothelial cells and tubular epithelial cells), and macrophage-myofibroblast transition. The differentiation and cross-talks of macrophages ultimately result renal inflammation and fibrosis in DN. Emerging evidence shows that targeting macrophages by suppressing macrophage activation/transition, and macrophages-cell interactions may be a promising approach to attenuate DN. In the review, we summarized the diverse roles of macrophages and the cross-talks to other cells in DN, and highlighted the therapeutic potentials by targeting macrophages.

Citing Articles

Anti-Inflammatory Effects of SGLT2 Inhibitors: Focus on Macrophages.

Rykova E, Klimontov V, Shmakova E, Korbut A, Merkulova T, Kzhyshkowska J Int J Mol Sci. 2025; 26(4).

PMID: 40004134 PMC: 11854991. DOI: 10.3390/ijms26041670.

Anemia in diabetes mellitus: Pathogenetic aspects and the value of early erythropoietin therapy.

Antoniadou C, Gavriilidis E, Ritis K, Tsilingiris D Metabol Open. 2025; 25:100344.

PMID: 39886103 PMC: 11780985. DOI: 10.1016/j.metop.2024.100344.

Interplay between periodontitis and chronic kidney disease.

Chapple I, Hirschfeld J, Cockwell P, Dietrich T, Sharma P Nat Rev Nephrol. 2024; .

PMID: 39658571 DOI: 10.1038/s41581-024-00910-5.

Mechanism of Yi-Qi-Bu-Shen Recipe for the Treatment of Diabetic Nephropathy Complicated with Cognitive Dysfunction Based on Network Pharmacology and Experimental Validation.

Li W, Liu Z, Song M, Shi Z, Zhang J, Zhou J Diabetes Metab Syndr Obes. 2024; 17:3943-3963.

PMID: 39465123 PMC: 11512782. DOI: 10.2147/DMSO.S481740.

Fiery Connections: Macrophage-Mediated Inflammation, the Journey from Obesity to Type 2 Diabetes Mellitus and Diabetic Kidney Disease.

Sinha S, Carpio M, Nicholas S Biomedicines. 2024; 12(10).

PMID: 39457523 PMC: 11503991. DOI: 10.3390/biomedicines12102209.

References

Lim A, Ma F, Nikolic-Paterson D, Thomas M, HURST L, Tesch G . Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice. Diabetologia. 2009; 52(8):1669-79. DOI: 10.1007/s00125-009-1399-3. View

Mirza R, Fang M, Weinheimer-Haus E, Ennis W, Koh T . Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice. Diabetes. 2013; 63(3):1103-14. PMC: 3931398. DOI: 10.2337/db13-0927. View

Ninichuk V, Kulkarni O, Clauss S, Anders H . Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy. Eur J Med Res. 2007; 12(8):351-5. View

Awad A, Kinsey G, Khutsishvili K, Gao T, Bolton W, Okusa M . Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury. Am J Physiol Renal Physiol. 2011; 301(6):F1358-66. PMC: 3233863. DOI: 10.1152/ajprenal.00332.2011. View

Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y . Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice. Diabetologia. 2012; 55(8):2256-66. DOI: 10.1007/s00125-012-2578-1. View

Kang Y, Lee M, Song H, Ko G, Kwon O, Lim T . CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice. Kidney Int. 2010; 78(9):883-94. DOI: 10.1038/ki.2010.263. View

Sheng J, Ruedl C, Karjalainen K . Most Tissue-Resident Macrophages Except Microglia Are Derived from Fetal Hematopoietic Stem Cells. Immunity. 2015; 43(2):382-93. DOI: 10.1016/j.immuni.2015.07.016. View

Nguyen T, Tarnow L, Andersen S, Hovind P, Parving H, Goldschmeding R . Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy. Diabetes Care. 2005; 29(1):83-8. DOI: 10.2337/diacare.29.1.83. View

Mohan S, Reddick R, Musi N, Horn D, Yan B, Prihoda T . Diabetic eNOS knockout mice develop distinct macro- and microvascular complications. Lab Invest. 2008; 88(5):515-28. DOI: 10.1038/labinvest.2008.23. View

10.

Li K, Li Q . LINC00323 mediates the role of M1 macrophage polarization in diabetic nephropathy through PI3K/AKT signaling pathway. Hum Immunol. 2021; 82(12):960-967. DOI: 10.1016/j.humimm.2021.08.010. View

11.

Lee E, Lee M, Kwon M, Kim H, Kang J, Kim Y . Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice. PLoS One. 2017; 12(6):e0179221. PMC: 5480859. DOI: 10.1371/journal.pone.0179221. View

12.

Munro D, Hughes J . The Origins and Functions of Tissue-Resident Macrophages in Kidney Development. Front Physiol. 2017; 8:837. PMC: 5660965. DOI: 10.3389/fphys.2017.00837. View

13.

Seron D, Cameron J, Haskard D . Expression of VCAM-1 in the normal and diseased kidney. Nephrol Dial Transplant. 1991; 6(12):917-22. DOI: 10.1093/ndt/6.12.917. View

14.

Li C, Su F, Liang Z, Zhang L, Liu F, Fan W . Macrophage M1 regulatory diabetic nephropathy is mediated by m6A methylation modification of lncRNA expression. Mol Immunol. 2022; 144:16-25. DOI: 10.1016/j.molimm.2022.02.008. View

15.

Prieur X, Roszer T, Ricote M . Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome. Biochim Biophys Acta. 2009; 1801(3):327-37. DOI: 10.1016/j.bbalip.2009.09.017. View

16.

Opazo-Rios L, Mas S, Marin-Royo G, Mezzano S, Gomez-Guerrero C, Moreno J . Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities. Int J Mol Sci. 2020; 21(7). PMC: 7177360. DOI: 10.3390/ijms21072632. View

17.

Wilson P, Wu H, Kirita Y, Uchimura K, Ledru N, Rennke H . The single-cell transcriptomic landscape of early human diabetic nephropathy. Proc Natl Acad Sci U S A. 2019; 116(39):19619-19625. PMC: 6765272. DOI: 10.1073/pnas.1908706116. View

18.

Wang Z, Sun W, Li R, Liu Y . miRNA-93-5p in exosomes derived from M2 macrophages improves lipopolysaccharide-induced podocyte apoptosis by targeting Toll-like receptor 4. Bioengineered. 2022; 13(3):7683-7696. PMC: 9208503. DOI: 10.1080/21655979.2021.2023794. View

19.

Xu X, Qi X, Shao Y, Li Y, Fu X, Feng S . High glucose induced-macrophage activation through TGF-β-activated kinase 1 signaling pathway. Inflamm Res. 2016; 65(8):655-64. DOI: 10.1007/s00011-016-0948-8. View

20.

Tang P, Zhou S, Li C, Liao J, Xiao J, Wang Q . The proto-oncogene tyrosine protein kinase Src is essential for macrophage-myofibroblast transition during renal scarring. Kidney Int. 2017; 93(1):173-187. DOI: 10.1016/j.kint.2017.07.026. View